Sphingolipid mediators in cardiovascular cell biology and pathology

Circulation Research

Volumn 89, Issue 11, 2001, Pages 957-968

  Levade, Thierry ^a   Augé, Nathalie ^a   Veldman, Robert Jan ^a   Cuvillier, Olivier ^a   Négre Salvayre, Anne ^a   Salvayre, Robert ^a  

^a CHU RANGUEIL   (France)

Author keywords

Ceramide; Signal transduction; Sphingomyelin; Sphingosine 1 phosphate; Vascular cells

Indexed keywords

CERAMIDE; SPHINGOLIPID; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE;

ANGIOGENESIS; ANIMAL CELL; APOPTOSIS; ATHEROSCLEROSIS; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CYTOLOGY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HUMAN; HUMAN CELL; ION CURRENT; NONHUMAN; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE FIBER;

EID: 0035941415     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/hh2301.100350     Document Type: Review

References (166)

1. Sphingolipid metabolism and cell growth regulation
2. Ceramide in the eukaryotic stress response
3. Sphingolipids in atherosclerosis and vascular biology
4. Secretory sphingomyelinase
5. Sphingomyelin metabolites in vascular cell signaling and atherogenesis
6. An update of the enzymology and regulation of sphingomyelin metabolism
7. Physiology and pathophysiology of sphingolipid metabolism and signaling
8. Sphingolipid transport in eukaryotic cells
9. Intracellular transport and metabolism of sphingomyelin
10. Structure and function of sphingolipid- and cholesterol-rich membrane rafts
11. Sphingolipids: Second messengers, mediators and raft constituents in signaling
12. Biosynthesis of long-chain (sphingoid) bases from serine by LM cells
13. Subcellular localization and membrane topology of serine palmitoyltransferase, 3-dehydrosphinganine reductase, and sphinganine N-acyltransferase in mouse liver
14. Characterization of ceramide synthesis
15. Sphingomyelin synthesis in rat liver occurs predominantly at the cis and medial cisternae of the Golgi apparatus
16. Sphingomyelin is synthesized in the cis Golgi
17. Conversion of diacylglycerol to phosphatidylcholine on the basolateral surface of epithelial (Madin-Darby canine kidney) cells
18. The subcellular sites of sphingomyelin synthesis in BHK cells
19. Topology of glucosylceramide synthesis in Golgi membranes from porcine submaxillary glands
20. Synaptic vesicle ceramide kinase: A calcium-stimulated lipid kinase that co-purifies with brain synaptic vesicles
21. Ceramide-1-phosphate phosphatase activity in brain
22. Topology of glycosphingolipid degradation
23. Human acid sphingomyelinase: Isolation, nucleotide sequence and expression of the full-length and alternatively spliced cDNAs
24. Molecular cloning and characterization of a full-length cDNA encoding human acid ceramidase
25. Cloned mammalian neutral sphingomyelinase: Functions in sphingolipid signaling?
26. Molecular cloning, characterization, and expression of a novel human neutral sphingomyelinase
27. 2+-dependent neutral sphingomyelinase
28. Molecular cloning of the full-length cDNA encoding mouse neutral ceramidase
29. Molecular cloning and characterization of a human mitochondrial ceramidase
30. Cloning and characterization of a novel human alkaline ceramidase
31. Molecular cloning and functional characterization of murine sphingosine kinase
32. Identification and subcellular localization of sphinganine-phosphatases in rat liver
33. Molecular cloning and characterization of a lipid phosphohydrolase that degrades sphingosine-1-phosphate and induces cell death
34. Human sphingosine-1-phosphate lyase: cDNA cloning, functional expression studies and mapping to chromosome 10q22(1)
35. Signalling sphingomyelinases: Which, where, how and why?
36. Sphingosine-1-phosphate signalling in mammalian cells
37. Characterization of a ceramide-activated protein kinase: Stimulation by TNFα
38. Sphingomyelinase and ceramide activate mitogen-activated protein kinase in myeloid HL-60 cells
39. Ceramide activates the stress-activated protein kinases
40. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis
41. PKCζ is a molecular switch in signal transduction of TNFα, bifunctionally regulated by ceramide and arachidonic acid
42. Ceramide inactivates cellular protein kinase Cα
43. Selective ceramide binding to protein kinase C-α and -δ isoenzymes in renal mesangial cells
44. Ceramide stimulates a cytosolic protein phosphatase
45. TNF activates NF-ΚB by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown
46. Ceramide activates NFκB by inducing the processing of p105
47. TNFα signal transduction through ceramide
48. Dissociation of endogenous cellular ceramide from NF-κB activation
49. Ceramide is not a signal for TNF-induced gene expression but does cause programmed cell death in human vascular endothelial cells
50. Sphingosine-1-phosphate: Extracellular mediator or intracellular second messenger?
51. Induction and suppression of endothelial cell apoptosis by sphingolipids: A possible in vitro model for cell-cell interactions between platelets and endothelial cells
52. Sphingosine-1-phosphate as a major bioactive lysophospholipid that is released from platelets and interacts with endothelial cells
53. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1
54. An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein coupled receptors
55. Functions of a new family of sphingosine-1-phosphate receptors
56. 2+ mobilization, Ras-mitogen-activated protein kinase activation, and adenylate cyclase inhibition
57. Gi-mediated Cas tyrosine phosphorylation in vascular endothelial cells stimulated with sphingosine-1-phosphate: Possible involvement in cell motility enhancement in cooperation with Rho-mediated pathways
58. 12 families of heterotrimeric G proteins
59. Sphingosine-1-phosphate and lysophosphatidic acid stimulate endothelial cell migration
60. The sphingomyelin-ceramide signaling pathway is involved in oxidized low density lipoprotein-induced cell proliferation
61. Oxidized low density lipoproteins stimulate galactosyltransferase activity, ras activation, p44 mitogen activated protein kinase and c-fos expression in aortic smooth muscle cells
62. Potential role for ceramide in mitogen-activated protein kinase activation and proliferation of vascular smooth muscle cells induced by oxidized low density lipoprotein
63. Activation of sphingosine kinase by TNFα inhibits apoptosis in human endothelial cells
64. Differential regulation of sphingomyelinase and ceramidase activities by growth factors and cytokines. Implications for cellular proliferation and differentiation
65. Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens
66. Role of sphingosine 1-phosphate in the mitogenesis induced by oxidized low density lipoprotein in smooth muscle cells via activation of sphingomyelinase, ceramidase, and sphingosine kinase
67. Ceramide mimics TNFα in the induction of cell cycle arrest in endothelial cells
68. Impaired ceramide signalling in spontaneously hypertensive rat vascular smooth muscle: A possible mechanism for augmented cell proliferation
69. Ceramide in apoptosis: Does it really matter?
70. Ceramide and apoptosis
71. Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation
72. Oxidized low density lipoprotein induces apoptosis in cultured human umbilical vein endothelial cells by common and unique mechanisms
73. Apoptosis and activation of the sphingomyelin-ceramide pathway induced by oxidized low density lipoproteins are not causally related in ECV-304 endothelial cells
74. Ceramide induces aSMase expression: Implications for oxLDL-induced apoptosis
75. The role of antiapoptotic Bcl-2 family members in endothelial apoptosis elucidated with antisense oligonucleotides
76. VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling
77. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate
78. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate
79. Sphingosine-1-phosphate protects human umbilical vein endothelial cells from serum-deprived apoptosis by nitric oxide production
80. i-coupled cell surface receptor
81. Sphingosine-1-phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis
82. i protein-linked phospholipase C pathway
83. Inhibitory regulation of Rac activation, membrane ruffling, and cell migration by the G protein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3
84. Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell motility
85. 1-containing integrins
86. Endothelial cell inflammatory responses to TNFα
87. TNFα induces adhesion molecule expression through the sphingosine kinase pathway
88. High density lipoproteins interrupt the sphingosine kinase signaling pathway
89. Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-κB
90. Lactosylceramide mediates TNFα-induced intercellular adhesion molecule-1 (ICAM-1) expression and the adhesion of neutrophil in human umbilical vein endothelial cells
91. Induction of tissue factor production but not the upregulation of adhesion molecule expression by ceramide in human vascular endothelial cells
92. Intracellular calcium release mediated by sphingosine derivatives generated in cells
93. Activation of a high affinity Gi protein-coupled plasma membrane receptor by sphingosine-1-phosphate
94. Expression and characterization of Edg-1 receptors in rat cardiomyocytes: Calcium deregulation in response to sphingosine-1-phosphate
95. Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1
96. Sphingosylphosphocholine modulates the ryanodine receptor/calcium-release channel of cardiac sarcoplasmic reticulum membranes
97. 2+ channel conductance
98. 2+ current in adult rat ventricular myocytes
99. Sphingolipid actions on sodium and calcium currents of rat ventricular myocytes
100. Depression of excitability by sphingosine-1-phosphate in rat ventricular myocytes
101. A novel membrane receptor with high affinity for lysosphingomyelin and sphingosine-1-phosphate in atrial myocytes
102. KACh by sphingosine-1-phosphate in human atrial cardiomyocytes
103. Ceramide: A novel cell signaling mechanism for vasodilation
104. 2+ mobilization in rat aortic smooth muscle
105. TNFα-induced endothelium-independent vasodilation: A role for phospholipase A2-dependent ceramide signaling
106. i in canine cerebral vascular muscle
107. Src kinase and PI3-kinase as a transduction pathway in ceramide-induced contraction of colonic smooth muscle
108. Effects of sphingomyelinase and sphingosine on arterial vasomotor regulation
109. Sphingosine-1-phosphate and sphingosylphosphorylcholine constrict renal and mesenteric microvessels in vitro
110. 2+-sensitization of vascular smooth muscle contraction: Possible involvement of rho-kinase
111. 2+ elevation in endothelial cells in situ and causes endothelium-dependent relaxation through nitric oxide production in bovine coronary artery
112. Ceramide reduces endothelium-dependent vasodilation by increasing superoxide production in small bovine coronary arteries
113. Nitric oxide donors induce stress signaling via ceramide formation in rat renal mesangial cells
114. Angiogenesis in cancer and other diseases
115. Sphingosine-1-phosphate induces angiogenesis: Its angiogenic action and signaling mechanism in human umbilical vein endothelial cells
116. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation
117. A sphingosine-1-phosphate receptor regulates cell migration during vertebrate heart development
118. Current perspective on the role of apoptosis in atherothrombotic disease
119. Lipotoxic heart disease in obese rats: Implications for human obesity
120. Sphingomyelinase and cell-permeable ceramide analogs increase the release of plasminogen activator inhibitor-1 from cultured endothelial cells
121. Plasma glucosylceramide deficiency as potential risk factor for venous thrombosis and modulator of anticoagulant protein C pathway
122. Modes of myocardial cell injury and cell death in ischemic heart disease
123. Apoptosis in myocardial ischemia-reperfusion
124. Ceramide is involved in triggering of cardiomyocyte apoptosis induced by ischemia and reperfusion
125. Altered ceramide and sphingosine expression during the induction phase of ischemic acute renal failure
126. FK506 prevents stroke-induced generation of ceramide and apoptosis signaling
127. Lethal forebrain ischemia stimulates sphingomyelin hydrolysis and ceramide generation in the gerbil hippocampus
128. Pivotal role for acidic sphingomyelinase in cerebral ischemia-induced ceramide and cytokine production, and neuronal apoptosis
129. Rapid activation of neutral sphingomyelinase by hypoxia-reoxygenation of cardiac myocytes
130. The protective effect of ceramide in immature rat brain hypoxia-ischemia involves up-regulation of bcl-2 and reduction of TUNEL-positive cells
131. SPC-100270, a protein kinase C inhibitor, reduced hypoxic injury due to reperfusion following orthotopic liver transplantation in the rat
132. Beneficial effects of N,N,N-trimethylsphingosine following ischemia and reperfusion in the isolated perfused rat heart
133. The role of glycosphingolipids in hypoxic cell injury
134. Anthracycline-induced cardiotoxicity
135. L-Carnitine prevents doxorubicin-induced apoptosis of cardiac myocytes: Role of inhibition of ceramide generation
136. Daunorubicin-induced apoptosis in rat cardiac myocytes is inhibited by dexrazoxane
137. TNFα-induced apoptosis in cardiac myocytes
138. Ceramide mediates radiation-induced death of endothelium
139. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis
140. Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis
141. Radiation-induced apoptosis of endothelial cells in the murine central nervous system: Protection by fibroblast growth factor and sphingomyelinase deficiency
142. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice
143. Fumonisins: Fungal toxins that shed light on sphingolipid function
144. Structural elucidation of scyphostatin, an inhibitor of membrane-bound neutral sphingomyelinase
145. Reduction of globotriaosylceramide in Fabry disease mice by substrate deprivation
146. Ceramide-coated balloon catheters limit neointimal hyperplasia after stretch injury in carotid arteries
147. Differential stimulation of proline-rich tyrosine kinase 2 and mitogen-activated protein kinase by sphingosine-1-phosphate
148. Sphingosine-1-phosphate stimulates proliferation and migration of human endothelial cells possibly through the lipid receptors, Edg-1 and Edg-3
149. Sphingosylphosphorylcholine induces a hypertrophic growth response through the mitogen-activated protein kinase signaling cascade in rat neonatal cardiac myocytes
150. Sphingosine-1-phosphate regulates heat shock protein 27 induction by a p38 MAP kinase-dependent mechanism in aortic smooth muscle cells
151. Activation of protein-tyrosine kinase Syk in human platelets stimulated with lysophosphatidic acid or sphingosine-1-phosphate
152. Ceramide-induced vasorelaxation: An inhibitory action on protein kinase C
153. Sphingosine-1-phosphate and activation of endothelial nitric-oxide synthase
154. Sphingosine-1-phosphate activates Akt, nitric oxide production and chemotaxis through a Gi-protein/phosphoinositide-3-kinase pathway in endothelial cells
155. Rho-mediated phosphorylation of focal adhesion kinase and myosin light chain in human endothelial cells stimulated with sphingosine-1-phosphate
156. Activation of endothelial cell phospholipase D by sphingosine and sphingosine-1-phosphate
157. Regulatory role of ceramide in interleukin (IL)-1-β-induced E-selectin expression in human umbilical vein endothelial cells
158. Calcium-independent activation of endothelial nitric oxide synthase by ceramide
159. Lactosylceramide stimulates human neutrophils to upregulate Mac-1, adhere to endothelium, and generate reactive oxygen metabolites in vitro
160. Sphingosine-1-phosphate stimulates G(i)- and Rho-mediated vascular endothelial cell spreading and migration
161. 2+ modulates membrane sphingolipid and lipid second messenger levels in vascular smooth muscle cells
162. Functional expression of Fas and Fas ligand on human gut lamina propria T lymphocytes
163. Growth-dependent regulation of cellular ceramides in human T-cells
164. CD28 signals through acidic sphingomyelinase
165. Apoptosis caused by oxidized LDL is manganese superoxide dismutase and p53 dependent
166. Sphingosine-1-phosphate induces platelet activation through an extracellular action and shares a platelet surface receptor with lysophosphatidic acid